Historical record - last NADAC effective date: 1/5/2018
Product Information
LUZU 1% CREAM is a brand product labeled by Bausch Health US LLC, priced at $7.9476 per GM under NDC 99207085060. Its NADAC has been published 231 times since Aug 20, 2014.
FDA first approved this application on Nov 14, 2013.
Strength
10 mg/g
Manufacturer
Bausch Health US LLCNDC
99207085060
Classification
Brand
Dosage Form
CREAM
Route
TOPICAL
Effective Date
1/5/2018
Active Ingredients
LULICONAZOLEApproval Type
New Drug (NDA)
FDA Application
NDA204153FDA Approved
11/14/2013
On Market Since
11/14/2013
Pharmacological Classes
Price Statistics
The NADAC for LUZU 1% CREAM has been published 231 times since Aug 20, 2014, and over the history we have for it it has risen 29.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.9476 per GM |
|---|---|
| All-time high | $7.9476 (Jan 16, 2019) |
| All-time low | $6.1195 (Sep 17, 2014) |
| Median price | $6.7894 |
| Average price | $7.0378 |
| Largest weekly change | +9.0% (Jan 18, 2017) |
| Weeks tracked | 231 |
| Tracking since | Aug 20, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+29.2%
Last surveyed Jan 16, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 66% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch Health US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
LULICONAZOLE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Azole Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LUZU 1% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for LUZU 1% CREAM, manufactured by Bausch Health US LLC, is $7.9476 per GM (NDC 99207085060), effective Jan 16, 2019.
How has the price of LUZU 1% CREAM changed over time?
Over the history we have for it, the NADAC for LUZU 1% CREAM has risen 29.2%. It has been tracked across 231 weekly CMS publications since Aug 20, 2014.
What are the highest and lowest recorded NADAC prices for LUZU 1% CREAM?
Since Aug 20, 2014, the NADAC for LUZU 1% CREAM has ranged from a low of $6.1195 (Sep 17, 2014) to a high of $7.9476 (Jan 16, 2019), with a median of $6.7894 per GM.
Are there cheaper alternatives to LUZU 1% CREAM?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LULICONAZOLE 1% CREAM, is $2.6814 per GM — about 66% below LUZU 1% CREAM.
Who manufactures LUZU 1% CREAM?
LUZU 1% CREAM (NDC 99207085060) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.